Table of Content

1 Study Coverage
1.1 Remicade Biosimilar Product Introduction
1.2 Market by Type
1.2.1 Global Remicade Biosimilar Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 100mg/10ml
1.2.3 500mg/50ml
1.3 Market by Application
1.3.1 Global Remicade Biosimilar Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Remicade Biosimilar Sales Estimates and Forecasts 2018-2029
2.2 Global Remicade Biosimilar Revenue by Region
2.2.1 Global Remicade Biosimilar Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Remicade Biosimilar Revenue by Region (2018-2024)
2.2.3 Global Remicade Biosimilar Revenue by Region (2024-2029)
2.2.4 Global Remicade Biosimilar Revenue Market Share by Region (2018-2029)
2.3 Global Remicade Biosimilar Sales Estimates and Forecasts 2018-2029
2.4 Global Remicade Biosimilar Sales by Region
2.4.1 Global Remicade Biosimilar Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Remicade Biosimilar Sales by Region (2018-2024)
2.4.3 Global Remicade Biosimilar Sales by Region (2024-2029)
2.4.4 Global Remicade Biosimilar Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Remicade Biosimilar Sales by Manufacturers
3.1.1 Global Remicade Biosimilar Sales by Manufacturers (2018-2024)
3.1.2 Global Remicade Biosimilar Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Remicade Biosimilar in 2022
3.2 Global Remicade Biosimilar Revenue by Manufacturers
3.2.1 Global Remicade Biosimilar Revenue by Manufacturers (2018-2024)
3.2.2 Global Remicade Biosimilar Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Remicade Biosimilar Revenue in 2022
3.3 Global Key Players of Remicade Biosimilar, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Remicade Biosimilar Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Remicade Biosimilar, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Remicade Biosimilar, Product Offered and Application
3.8 Global Key Manufacturers of Remicade Biosimilar, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Remicade Biosimilar Sales by Type
4.1.1 Global Remicade Biosimilar Historical Sales by Type (2018-2024)
4.1.2 Global Remicade Biosimilar Forecasted Sales by Type (2024-2029)
4.1.3 Global Remicade Biosimilar Sales Market Share by Type (2018-2029)
4.2 Global Remicade Biosimilar Revenue by Type
4.2.1 Global Remicade Biosimilar Historical Revenue by Type (2018-2024)
4.2.2 Global Remicade Biosimilar Forecasted Revenue by Type (2024-2029)
4.2.3 Global Remicade Biosimilar Revenue Market Share by Type (2018-2029)
4.3 Global Remicade Biosimilar Price by Type
4.3.1 Global Remicade Biosimilar Price by Type (2018-2024)
4.3.2 Global Remicade Biosimilar Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Remicade Biosimilar Sales by Application
5.1.1 Global Remicade Biosimilar Historical Sales by Application (2018-2024)
5.1.2 Global Remicade Biosimilar Forecasted Sales by Application (2024-2029)
5.1.3 Global Remicade Biosimilar Sales Market Share by Application (2018-2029)
5.2 Global Remicade Biosimilar Revenue by Application
5.2.1 Global Remicade Biosimilar Historical Revenue by Application (2018-2024)
5.2.2 Global Remicade Biosimilar Forecasted Revenue by Application (2024-2029)
5.2.3 Global Remicade Biosimilar Revenue Market Share by Application (2018-2029)
5.3 Global Remicade Biosimilar Price by Application
5.3.1 Global Remicade Biosimilar Price by Application (2018-2024)
5.3.2 Global Remicade Biosimilar Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Remicade Biosimilar Market Size by Type
6.1.1 US & Canada Remicade Biosimilar Sales by Type (2018-2029)
6.1.2 US & Canada Remicade Biosimilar Revenue by Type (2018-2029)
6.2 US & Canada Remicade Biosimilar Market Size by Application
6.2.1 US & Canada Remicade Biosimilar Sales by Application (2018-2029)
6.2.2 US & Canada Remicade Biosimilar Revenue by Application (2018-2029)
6.3 US & Canada Remicade Biosimilar Market Size by Country
6.3.1 US & Canada Remicade Biosimilar Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Remicade Biosimilar Sales by Country (2018-2029)
6.3.3 US & Canada Remicade Biosimilar Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Remicade Biosimilar Market Size by Type
7.1.1 Europe Remicade Biosimilar Sales by Type (2018-2029)
7.1.2 Europe Remicade Biosimilar Revenue by Type (2018-2029)
7.2 Europe Remicade Biosimilar Market Size by Application
7.2.1 Europe Remicade Biosimilar Sales by Application (2018-2029)
7.2.2 Europe Remicade Biosimilar Revenue by Application (2018-2029)
7.3 Europe Remicade Biosimilar Market Size by Country
7.3.1 Europe Remicade Biosimilar Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Remicade Biosimilar Sales by Country (2018-2029)
7.3.3 Europe Remicade Biosimilar Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Remicade Biosimilar Market Size
8.1.1 China Remicade Biosimilar Sales (2018-2029)
8.1.2 China Remicade Biosimilar Revenue (2018-2029)
8.2 China Remicade Biosimilar Market Size by Application
8.2.1 China Remicade Biosimilar Sales by Application (2018-2029)
8.2.2 China Remicade Biosimilar Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Remicade Biosimilar Market Size by Type
9.1.1 Asia Remicade Biosimilar Sales by Type (2018-2029)
9.1.2 Asia Remicade Biosimilar Revenue by Type (2018-2029)
9.2 Asia Remicade Biosimilar Market Size by Application
9.2.1 Asia Remicade Biosimilar Sales by Application (2018-2029)
9.2.2 Asia Remicade Biosimilar Revenue by Application (2018-2029)
9.3 Asia Remicade Biosimilar Sales by Region
9.3.1 Asia Remicade Biosimilar Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Remicade Biosimilar Revenue by Region (2018-2029)
9.3.3 Asia Remicade Biosimilar Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Remicade Biosimilar Market Size by Type
10.1.1 Middle East, Africa and Latin America Remicade Biosimilar Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Remicade Biosimilar Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Remicade Biosimilar Market Size by Application
10.2.1 Middle East, Africa and Latin America Remicade Biosimilar Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Remicade Biosimilar Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Remicade Biosimilar Sales by Country
10.3.1 Middle East, Africa and Latin America Remicade Biosimilar Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Remicade Biosimilar Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Remicade Biosimilar Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Synthon Pharmaceuticals
11.1.1 Synthon Pharmaceuticals Company Information
11.1.2 Synthon Pharmaceuticals Overview
11.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Synthon Pharmaceuticals Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Synthon Pharmaceuticals Recent Developments
11.2 LG Life Sciences
11.2.1 LG Life Sciences Company Information
11.2.2 LG Life Sciences Overview
11.2.3 LG Life Sciences Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 LG Life Sciences Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 LG Life Sciences Recent Developments
11.3 Novartis (Sandoz)
11.3.1 Novartis (Sandoz) Company Information
11.3.2 Novartis (Sandoz) Overview
11.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novartis (Sandoz) Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis (Sandoz) Recent Developments
11.4 Celltrion
11.4.1 Celltrion Company Information
11.4.2 Celltrion Overview
11.4.3 Celltrion Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Celltrion Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Celltrion Recent Developments
11.5 Biocon
11.5.1 Biocon Company Information
11.5.2 Biocon Overview
11.5.3 Biocon Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Biocon Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biocon Recent Developments
11.6 Hospira
11.6.1 Hospira Company Information
11.6.2 Hospira Overview
11.6.3 Hospira Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Hospira Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hospira Recent Developments
11.7 Merck Serono (Merck Group)
11.7.1 Merck Serono (Merck Group) Company Information
11.7.2 Merck Serono (Merck Group) Overview
11.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Merck Serono (Merck Group) Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Serono (Merck Group) Recent Developments
11.8 Biogen idec Inc.
11.8.1 Biogen idec Inc. Company Information
11.8.2 Biogen idec Inc. Overview
11.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Biogen idec Inc. Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biogen idec Inc. Recent Developments
11.9 Genentech (Roche Group)
11.9.1 Genentech (Roche Group) Company Information
11.9.2 Genentech (Roche Group) Overview
11.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Genentech (Roche Group) Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Genentech (Roche Group) Recent Developments
11.10 Fosun Pharmaceutical
11.10.1 Fosun Pharmaceutical Company Information
11.10.2 Fosun Pharmaceutical Overview
11.10.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Fosun Pharmaceutical Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Fosun Pharmaceutical Recent Developments
11.11 Livzon Pharmaceutical
11.11.1 Livzon Pharmaceutical Company Information
11.11.2 Livzon Pharmaceutical Overview
11.11.3 Livzon Pharmaceutical Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Livzon Pharmaceutical Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Livzon Pharmaceutical Recent Developments
11.12 Anke Biotechnology
11.12.1 Anke Biotechnology Company Information
11.12.2 Anke Biotechnology Overview
11.12.3 Anke Biotechnology Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Anke Biotechnology Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Anke Biotechnology Recent Developments
11.13 Hualan Biological Engineering
11.13.1 Hualan Biological Engineering Company Information
11.13.2 Hualan Biological Engineering Overview
11.13.3 Hualan Biological Engineering Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Hualan Biological Engineering Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Hualan Biological Engineering Recent Developments
11.14 Walvax Biotechnology
11.14.1 Walvax Biotechnology Company Information
11.14.2 Walvax Biotechnology Overview
11.14.3 Walvax Biotechnology Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Walvax Biotechnology Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Walvax Biotechnology Recent Developments
11.15 Hisun Pharmaceutical
11.15.1 Hisun Pharmaceutical Company Information
11.15.2 Hisun Pharmaceutical Overview
11.15.3 Hisun Pharmaceutical Remicade Biosimilar Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Hisun Pharmaceutical Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Hisun Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Remicade Biosimilar Industry Chain Analysis
12.2 Remicade Biosimilar Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Remicade Biosimilar Production Mode & Process
12.4 Remicade Biosimilar Sales and Marketing
12.4.1 Remicade Biosimilar Sales Channels
12.4.2 Remicade Biosimilar Distributors
12.5 Remicade Biosimilar Customers
13 Market Dynamics
13.1 Remicade Biosimilar Industry Trends
13.2 Remicade Biosimilar Market Drivers
13.3 Remicade Biosimilar Market Challenges
13.4 Remicade Biosimilar Market Restraints
14 Key Findings in The Global Remicade Biosimilar Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Remicade Biosimilar Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 100mg/10ml
Table 3. Major Manufacturers of 500mg/50ml
Table 4. Global Remicade Biosimilar Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Remicade Biosimilar Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Remicade Biosimilar Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Remicade Biosimilar Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Remicade Biosimilar Revenue Market Share by Region (2018-2024)
Table 9. Global Remicade Biosimilar Revenue Market Share by Region (2024-2029)
Table 10. Global Remicade Biosimilar Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Remicade Biosimilar Sales by Region (2018-2024) & (L)
Table 12. Global Remicade Biosimilar Sales by Region (2024-2029) & (L)
Table 13. Global Remicade Biosimilar Sales Market Share by Region (2018-2024)
Table 14. Global Remicade Biosimilar Sales Market Share by Region (2024-2029)
Table 15. Global Remicade Biosimilar Sales by Manufacturers (2018-2024) & (L)
Table 16. Global Remicade Biosimilar Sales Share by Manufacturers (2018-2024)
Table 17. Global Remicade Biosimilar Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Remicade Biosimilar Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Remicade Biosimilar, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Remicade Biosimilar Price by Manufacturers 2018-2024 (US$/Ml)
Table 21. Global Remicade Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Remicade Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Remicade Biosimilar as of 2022)
Table 23. Global Key Manufacturers of Remicade Biosimilar, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Remicade Biosimilar, Product Offered and Application
Table 25. Global Key Manufacturers of Remicade Biosimilar, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Remicade Biosimilar Sales by Type (2018-2024) & (L)
Table 28. Global Remicade Biosimilar Sales by Type (2024-2029) & (L)
Table 29. Global Remicade Biosimilar Sales Share by Type (2018-2024)
Table 30. Global Remicade Biosimilar Sales Share by Type (2024-2029)
Table 31. Global Remicade Biosimilar Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Remicade Biosimilar Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Remicade Biosimilar Revenue Share by Type (2018-2024)
Table 34. Global Remicade Biosimilar Revenue Share by Type (2024-2029)
Table 35. Remicade Biosimilar Price by Type (2018-2024) & (US$/Ml)
Table 36. Global Remicade Biosimilar Price Forecast by Type (2024-2029) & (US$/Ml)
Table 37. Global Remicade Biosimilar Sales by Application (2018-2024) & (L)
Table 38. Global Remicade Biosimilar Sales by Application (2024-2029) & (L)
Table 39. Global Remicade Biosimilar Sales Share by Application (2018-2024)
Table 40. Global Remicade Biosimilar Sales Share by Application (2024-2029)
Table 41. Global Remicade Biosimilar Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Remicade Biosimilar Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Remicade Biosimilar Revenue Share by Application (2018-2024)
Table 44. Global Remicade Biosimilar Revenue Share by Application (2024-2029)
Table 45. Remicade Biosimilar Price by Application (2018-2024) & (US$/Ml)
Table 46. Global Remicade Biosimilar Price Forecast by Application (2024-2029) & (US$/Ml)
Table 47. US & Canada Remicade Biosimilar Sales by Type (2018-2024) & (L)
Table 48. US & Canada Remicade Biosimilar Sales by Type (2024-2029) & (L)
Table 49. US & Canada Remicade Biosimilar Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Remicade Biosimilar Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Remicade Biosimilar Sales by Application (2018-2024) & (L)
Table 52. US & Canada Remicade Biosimilar Sales by Application (2024-2029) & (L)
Table 53. US & Canada Remicade Biosimilar Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Remicade Biosimilar Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Remicade Biosimilar Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Remicade Biosimilar Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Remicade Biosimilar Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Remicade Biosimilar Sales by Country (2018-2024) & (L)
Table 59. US & Canada Remicade Biosimilar Sales by Country (2024-2029) & (L)
Table 60. Europe Remicade Biosimilar Sales by Type (2018-2024) & (L)
Table 61. Europe Remicade Biosimilar Sales by Type (2024-2029) & (L)
Table 62. Europe Remicade Biosimilar Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Remicade Biosimilar Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Remicade Biosimilar Sales by Application (2018-2024) & (L)
Table 65. Europe Remicade Biosimilar Sales by Application (2024-2029) & (L)
Table 66. Europe Remicade Biosimilar Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Remicade Biosimilar Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Remicade Biosimilar Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Remicade Biosimilar Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Remicade Biosimilar Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Remicade Biosimilar Sales by Country (2018-2024) & (L)
Table 72. Europe Remicade Biosimilar Sales by Country (2024-2029) & (L)
Table 73. China Remicade Biosimilar Sales by Type (2018-2024) & (L)
Table 74. China Remicade Biosimilar Sales by Type (2024-2029) & (L)
Table 75. China Remicade Biosimilar Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Remicade Biosimilar Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Remicade Biosimilar Sales by Application (2018-2024) & (L)
Table 78. China Remicade Biosimilar Sales by Application (2024-2029) & (L)
Table 79. China Remicade Biosimilar Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Remicade Biosimilar Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Remicade Biosimilar Sales by Type (2018-2024) & (L)
Table 82. Asia Remicade Biosimilar Sales by Type (2024-2029) & (L)
Table 83. Asia Remicade Biosimilar Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Remicade Biosimilar Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Remicade Biosimilar Sales by Application (2018-2024) & (L)
Table 86. Asia Remicade Biosimilar Sales by Application (2024-2029) & (L)
Table 87. Asia Remicade Biosimilar Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Remicade Biosimilar Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Remicade Biosimilar Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Remicade Biosimilar Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Remicade Biosimilar Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Remicade Biosimilar Sales by Region (2018-2024) & (L)
Table 93. Asia Remicade Biosimilar Sales by Region (2024-2029) & (L)
Table 94. Middle East, Africa and Latin America Remicade Biosimilar Sales by Type (2018-2024) & (L)
Table 95. Middle East, Africa and Latin America Remicade Biosimilar Sales by Type (2024-2029) & (L)
Table 96. Middle East, Africa and Latin America Remicade Biosimilar Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Remicade Biosimilar Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Remicade Biosimilar Sales by Application (2018-2024) & (L)
Table 99. Middle East, Africa and Latin America Remicade Biosimilar Sales by Application (2024-2029) & (L)
Table 100. Middle East, Africa and Latin America Remicade Biosimilar Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Remicade Biosimilar Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Remicade Biosimilar Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Remicade Biosimilar Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Remicade Biosimilar Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Remicade Biosimilar Sales by Country (2018-2024) & (L)
Table 106. Middle East, Africa and Latin America Remicade Biosimilar Sales by Country (2024-2029) & (L)
Table 107. Synthon Pharmaceuticals Company Information
Table 108. Synthon Pharmaceuticals Description and Major Businesses
Table 109. Synthon Pharmaceuticals Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 110. Synthon Pharmaceuticals Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Synthon Pharmaceuticals Recent Developments
Table 112. LG Life Sciences Company Information
Table 113. LG Life Sciences Description and Major Businesses
Table 114. LG Life Sciences Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 115. LG Life Sciences Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. LG Life Sciences Recent Developments
Table 117. Novartis (Sandoz) Company Information
Table 118. Novartis (Sandoz) Description and Major Businesses
Table 119. Novartis (Sandoz) Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 120. Novartis (Sandoz) Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Novartis (Sandoz) Recent Developments
Table 122. Celltrion Company Information
Table 123. Celltrion Description and Major Businesses
Table 124. Celltrion Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 125. Celltrion Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Celltrion Recent Developments
Table 127. Biocon Company Information
Table 128. Biocon Description and Major Businesses
Table 129. Biocon Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 130. Biocon Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Biocon Recent Developments
Table 132. Hospira Company Information
Table 133. Hospira Description and Major Businesses
Table 134. Hospira Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 135. Hospira Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Hospira Recent Developments
Table 137. Merck Serono (Merck Group) Company Information
Table 138. Merck Serono (Merck Group) Description and Major Businesses
Table 139. Merck Serono (Merck Group) Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 140. Merck Serono (Merck Group) Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Merck Serono (Merck Group) Recent Developments
Table 142. Biogen idec Inc. Company Information
Table 143. Biogen idec Inc. Description and Major Businesses
Table 144. Biogen idec Inc. Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 145. Biogen idec Inc. Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Biogen idec Inc. Recent Developments
Table 147. Genentech (Roche Group) Company Information
Table 148. Genentech (Roche Group) Description and Major Businesses
Table 149. Genentech (Roche Group) Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 150. Genentech (Roche Group) Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Genentech (Roche Group) Recent Developments
Table 152. Fosun Pharmaceutical Company Information
Table 153. Fosun Pharmaceutical Description and Major Businesses
Table 154. Fosun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 155. Fosun Pharmaceutical Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Fosun Pharmaceutical Recent Developments
Table 157. Livzon Pharmaceutical Company Information
Table 158. Livzon Pharmaceutical Description and Major Businesses
Table 159. Livzon Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 160. Livzon Pharmaceutical Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Livzon Pharmaceutical Recent Developments
Table 162. Anke Biotechnology Company Information
Table 163. Anke Biotechnology Description and Major Businesses
Table 164. Anke Biotechnology Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 165. Anke Biotechnology Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Anke Biotechnology Recent Developments
Table 167. Hualan Biological Engineering Company Information
Table 168. Hualan Biological Engineering Description and Major Businesses
Table 169. Hualan Biological Engineering Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 170. Hualan Biological Engineering Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Hualan Biological Engineering Recent Developments
Table 172. Walvax Biotechnology Company Information
Table 173. Walvax Biotechnology Description and Major Businesses
Table 174. Walvax Biotechnology Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 175. Walvax Biotechnology Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Walvax Biotechnology Recent Developments
Table 177. Hisun Pharmaceutical Company Information
Table 178. Hisun Pharmaceutical Description and Major Businesses
Table 179. Hisun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 180. Hisun Pharmaceutical Remicade Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Hisun Pharmaceutical Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Remicade Biosimilar Distributors List
Table 185. Remicade Biosimilar Customers List
Table 186. Remicade Biosimilar Market Trends
Table 187. Remicade Biosimilar Market Drivers
Table 188. Remicade Biosimilar Market Challenges
Table 189. Remicade Biosimilar Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Remicade Biosimilar Product Picture
Figure 2. Global Remicade Biosimilar Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Remicade Biosimilar Market Share by Type in 2022 & 2029
Figure 4. 100mg/10ml Product Picture
Figure 5. 500mg/50ml Product Picture
Figure 6. Global Remicade Biosimilar Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Remicade Biosimilar Market Share by Application in 2022 & 2029
Figure 8. Blood Disorders
Figure 9. Oncology Diseases
Figure 10. Remicade Biosimilar Report Years Considered
Figure 11. Global Remicade Biosimilar Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Remicade Biosimilar Revenue 2018-2029 (US$ Million)
Figure 13. Global Remicade Biosimilar Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Remicade Biosimilar Revenue Market Share by Region (2018-2029)
Figure 15. Global Remicade Biosimilar Sales 2018-2029 ((L)
Figure 16. Global Remicade Biosimilar Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Remicade Biosimilar Sales YoY (2018-2029) & (L)
Figure 18. US & Canada Remicade Biosimilar Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Remicade Biosimilar Sales YoY (2018-2029) & (L)
Figure 20. Europe Remicade Biosimilar Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Remicade Biosimilar Sales YoY (2018-2029) & (L)
Figure 22. China Remicade Biosimilar Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Remicade Biosimilar Sales YoY (2018-2029) & (L)
Figure 24. Asia (excluding China) Remicade Biosimilar Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Remicade Biosimilar Sales YoY (2018-2029) & (L)
Figure 26. Middle East, Africa and Latin America Remicade Biosimilar Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Remicade Biosimilar Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Remicade Biosimilar in the World: Market Share by Remicade Biosimilar Revenue in 2022
Figure 29. Global Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Remicade Biosimilar Sales Market Share by Type (2018-2029)
Figure 31. Global Remicade Biosimilar Revenue Market Share by Type (2018-2029)
Figure 32. Global Remicade Biosimilar Sales Market Share by Application (2018-2029)
Figure 33. Global Remicade Biosimilar Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Remicade Biosimilar Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Remicade Biosimilar Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Remicade Biosimilar Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Remicade Biosimilar Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Remicade Biosimilar Revenue Share by Country (2018-2029)
Figure 39. US & Canada Remicade Biosimilar Sales Share by Country (2018-2029)
Figure 40. U.S. Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Remicade Biosimilar Sales Market Share by Type (2018-2029)
Figure 43. Europe Remicade Biosimilar Revenue Market Share by Type (2018-2029)
Figure 44. Europe Remicade Biosimilar Sales Market Share by Application (2018-2029)
Figure 45. Europe Remicade Biosimilar Revenue Market Share by Application (2018-2029)
Figure 46. Europe Remicade Biosimilar Revenue Share by Country (2018-2029)
Figure 47. Europe Remicade Biosimilar Sales Share by Country (2018-2029)
Figure 48. Germany Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 49. France Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 53. China Remicade Biosimilar Sales Market Share by Type (2018-2029)
Figure 54. China Remicade Biosimilar Revenue Market Share by Type (2018-2029)
Figure 55. China Remicade Biosimilar Sales Market Share by Application (2018-2029)
Figure 56. China Remicade Biosimilar Revenue Market Share by Application (2018-2029)
Figure 57. Asia Remicade Biosimilar Sales Market Share by Type (2018-2029)
Figure 58. Asia Remicade Biosimilar Revenue Market Share by Type (2018-2029)
Figure 59. Asia Remicade Biosimilar Sales Market Share by Application (2018-2029)
Figure 60. Asia Remicade Biosimilar Revenue Market Share by Application (2018-2029)
Figure 61. Asia Remicade Biosimilar Revenue Share by Region (2018-2029)
Figure 62. Asia Remicade Biosimilar Sales Share by Region (2018-2029)
Figure 63. Japan Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 67. India Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Remicade Biosimilar Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Remicade Biosimilar Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Remicade Biosimilar Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Remicade Biosimilar Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Remicade Biosimilar Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Remicade Biosimilar Sales Share by Country (2018-2029)
Figure 74. Brazil Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Remicade Biosimilar Revenue (2018-2029) & (US$ Million)
Figure 79. Remicade Biosimilar Value Chain
Figure 80. Remicade Biosimilar Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed